Anti-Cancer Drugs Targeting Tumor-Associated Macrophages
Author Information
Author(s): Bai Bingjun, Xie Shangzhi, Wang Ya, Wu Fei, Chen Yao, Bian Jia, Gao Xing
Primary Institution: Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China
Hypothesis
Targeting tumor-associated macrophages (TAMs) can enhance the efficacy of anti-cancer therapies.
Conclusion
This review highlights the potential of targeting TAMs as a promising strategy for improving cancer treatment outcomes.
Supporting Evidence
- TAMs play a crucial role in the tumor microenvironment and can influence cancer progression.
- Targeting M2-type TAMs is identified as a promising strategy for tumor therapy.
- Macrophage polarization is influenced by various factors, including cytokines and signaling pathways.
- Recent studies suggest that reprogramming TAMs can enhance anti-tumor immune responses.
Takeaway
Scientists are studying how to use special cells in tumors called macrophages to help fight cancer better.
Methodology
This is a comprehensive review summarizing existing research on TAMs and their role in cancer therapy.
Limitations
The review discusses challenges in targeting TAMs, including potential systemic toxicity and treatment resistance.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website